Strategies to tackle SARS-CoV-2 Mu, a newly classified variant of interest likely to resist currently available COVID-19 vaccines

Several severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) variants have recently been reported in many countries. These have exacerbated the coronavirus disease 2019 (COVID-19)-induced global health threats and hindered COVID-19 vaccine development and therapeutic progress. This commentar...

Descripción completa

Detalles Bibliográficos
Autores principales: Hossain, Md. Jamal, Rabaan, Ali A., Mutair, Abbas Al, Alhumaid, Saad, Emran, Talha Bin, Saikumar, G, Mitra, Saikat, Dhama, Kuldeep
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Taylor & Francis 2022
Materias:
Coronavirus – Commentary
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8862164/
https://www.ncbi.nlm.nih.gov/pubmed/35172687
http://dx.doi.org/10.1080/21645515.2022.2027197

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8862164/
https://www.ncbi.nlm.nih.gov/pubmed/35172687
http://dx.doi.org/10.1080/21645515.2022.2027197

Ejemplares similares